S1P – Rezeptor Modulation – eine gute per os Option für PatientInnen mit Colitis ulcerosa

Moschen, A. (Speaker)

Department of Internal Medicine 2 - Gastroenterology and Hepatology, Endocrinology and Metabolism, Nephrology, Rheumatology

Activity: Talk or presentation › Invited talk › science-to-science

Period	03 Sept 2025
Event title	CED & Etrasimod - Pfizer AT
Event type	Conference
Location	Wien, AustriaShow on map
Degree of Recognition	National

Fields of science

302016 Gastroenterology
302025 Hepatology
302030 Internal medicine